TARS — Tarsus Pharmaceuticals, Inc.
Materials · Biological Products, (No Diagnostic Substances) · Nasdaq
2Insiders filing
4Transactions
+$0Reported buys
−$1.7MReported sells
0Cluster events
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Lin Elizabeth Yeu | Chief Medical Officer | 3 | $898k |
| Azamian Bobak R. | President/CEO and Board Chair | 1 | $801k |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-02 | TARS | Lin Elizabeth Yeu Chief Medical Officer 10b5-1 | S | 5,387 | $80.00 | −$431k | |
| 2026-09-03 | 2026-09-02 | TARS | Lin Elizabeth Yeu Chief Medical Officer 10b5-1 | S | 1,590 | $80.00 | −$127k | |
| 2026-09-03 | 2026-09-02 | TARS | Azamian Bobak R. President/CEO and Board Chair 10b5-1 | S | 10,000 | $80.06 | −$801k | |
| 2026-09-03 | 2026-09-01 | TARS | Lin Elizabeth Yeu Chief Medical Officer 10b5-1 | S | 4,601 | $73.86 | −$340k |
No transactions match these filters.